These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7027392)

  • 21. [Captopril in mild or moderate systemic arterial hypertension].
    Spritzer N; Wolmeister H; Spritzer TS; Maciel R
    Arq Bras Cardiol; 1984 Jun; 42(6):447-50. PubMed ID: 6393923
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of captopril in acute and prolonged treatment of patients with hypertensive crisis].
    Saragoça MA; Ribeiro AB; Ramos OL; Pesquisadores E
    Arq Bras Cardiol; 1984 Mar; 42(3):227-30. PubMed ID: 6383296
    [No Abstract]   [Full Text] [Related]  

  • 24. Captopril in hypertensive crisis.
    Hauger-Klevene JH
    Lancet; 1985 Sep; 2(8457):732-3. PubMed ID: 2863719
    [No Abstract]   [Full Text] [Related]  

  • 25. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril in severe treatment-resistant hypertension.
    Ferguson RK; Vlasses PH; Koplin JR; Shirinian A; Burke JF; Alexander JC
    Am Heart J; 1980 May; 99(5):579-85. PubMed ID: 6989221
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A; Aguglia F; De Mattia G; Ficara C; Balsano F
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition.
    Covi G; Minuz P; Capuzzo G; Lechi C; Delva P; Lechi A
    Int J Clin Pharmacol Res; 1984; 4(1):47-52. PubMed ID: 6432714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic and clinical effects of long-term treatment of essential hypertension with captopril.
    Ricciardelli B; Volpe M; Trimarco B; De Luca N; Cuocolo A; Sacca' L; Condorelli M
    Eur Heart J; 1983 Jul; 4(7):496-501. PubMed ID: 6414815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indomethacin does not attenuate the hypotensive effect of captopril, a converting enzyme inhibitor in Goldblatt hypertensive rats.
    Omata K; Otsuka Y; Chiba S; Itoh T; Gotoh T; Imai Y; Sakurai Y; Satoh M; Haruyama T; Hiwatari M; Satoh K; Kaitoh A; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1981 May; 134(1):9-19. PubMed ID: 7031986
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypertensive crisis. Treatment with captopril after failure with a diuretic. Multicenter study].
    Saragoça M; Ribeiro AB; Ramos OL
    Arq Bras Cardiol; 1982 May; 38(5):415-9. PubMed ID: 6762867
    [No Abstract]   [Full Text] [Related]  

  • 32. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of captopril on blood pressure in neurogenic hypertensive dogs.
    Montastruc P; Montastruc JL
    Arch Farmacol Toxicol; 1983 Apr; 9(1):47-52. PubMed ID: 6354107
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term effects of captopril in hypertension.
    Maruyama A; Ogihara T; Naka T; Mikami H; Hata T; Nakamaru M; Iwanaga K; Kumahara Y
    Clin Pharmacol Ther; 1980 Sep; 28(3):316-23. PubMed ID: 6996895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
    Sullivan JM; Ginsburg BA; Ratts TE; Johnson JG; Barton BR; Kraus DH; McKinstry DN; Muirhead EE
    Hypertension; 1979; 1(4):397-401. PubMed ID: 232084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta blockade during captopril treatment for hypertension.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    N Engl J Med; 1980 Nov; 303(19):1121-2. PubMed ID: 6106894
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment.
    Vlasses PH; Rotmensch HH; Swanson BN; Mojaverian P; Ferguson RK
    Arch Intern Med; 1982 Jun; 142(6):1098-101. PubMed ID: 6284081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Captopril-induced changes in large arteries in essential hypertension.
    Simon AC; Levenson JA; Bouthier JL; Safar ME
    Am J Med; 1984 May; 76(5B):71-5. PubMed ID: 6328988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
    Millar JA; McGrath BP; Matthews PG; Johnston CI
    Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of low doses of captopril, alone or associated with diuretics, in the treatment of mild and moderate hypertension].
    Hatab SA; dos Santos AG
    Arq Bras Cardiol; 1984 Apr; 42(4):305-9. PubMed ID: 6391437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.